about/dr-rainer-boehm-profil
Board Member

Dr. Rainer Boehm

Dr. Rainer Boehm held several senior management positions during his career at Novartis Pharma AG, spanning from 1988 to 2017, such as Global Head of the Oncology Commercial Functions (2010-2013), Head of the Oncology in North America (2005-2010), Chief Commercial & Medical Affairs Officer (2014-2016) and briefly Interim CEO of Novartis Pharma AG (2016).

He was a key figure in the successful establishment of Novartis Oncology. He oversaw the launch and life cycle management of many blockbuster brands in different geographies or globally, amongst them Femara, Zometa and Gleevec, as well as Cosentyx and Entresto. Today he is a board member of several life science companies such as Cellectis SA, Humanigen Inc. and BioCopy AG.

Please use a modern web browser